| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |